Jon Marinelli Buys Shares of United States Antimony Corporation
Jon Marinelli acquired 12,500 shares of United States Antimony at $7.45 each.
Key Points
- On June 15, 2026, Jon Marinelli bought 12,500 shares of United States Antimony Corporation at $7.45 each, totaling $93,125.
- United States Antimony, trading at $7.09, has a market cap of about $1.05 billion and a forward P/E ratio of 20.85.
- Recent insider activity includes several sales by company executives, while analysts maintain a strong buy consensus.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Jon Marinelli, an insider at United States Antimony Corporation, purchased 12,500 shares of the company on June 15, 2026. The shares were bought at an average price of $7.45 each, amounting to a total value of $93,125. This transaction was not planned under a pre-arranged trading plan.
Other Institutional Activity in United States Antimony
VAN ECK ASSOCIATES CORP added a significant 10,369,695 shares, bringing its total to 10,369,695 shares valued at approximately $90.53 million. BLACKROCK, INC. increased its stake by 545,719 shares to a total of 9,883,038 shares worth about $86.28 million. STATE STREET CORP also added 378,051 shares, ending with 8,047,077 shares valued at $70.25 million. DRIEHAUS CAPITAL MANAGEMENT LLC significantly boosted its holdings by 4,052,162 shares, resulting in 5,345,710 shares valued at $46.67 million.
United States Antimony Corporation Stock Up 46.2%
Shares of United States Antimony Corporation (NYSE:UAMY) traded around $7.09. The company boasts a market capitalization of approximately $1.05 billion and a forward P/E ratio of 20.85, reflecting investor expectations of future earnings. The stock has a 52-week range between $1.94 and $19.71. It has a 50-day moving average of $9.41 and a 200-day moving average of $8.25. The company maintains a strong financial position with a current ratio of 3.62 and a quick ratio of 1.74.
Recent Earnings
United States Antimony reported revenues of $39.04 million, with a revenue decline of 3.1%. The company posted a negative net margin of 41.44% and a return on equity of -19.67%. The next earnings report is anticipated on August 14, 2026.
Insider Buying and Selling at United States Antimony Corporation
In addition to Jon Marinelli's recent purchase, there have been several insider sales. Richard Isaak, SVP and CFO, sold 100,000 shares at $9.75 on June 2, 2026. Lloyd Bardswich, Director and EVP, sold 59,872 shares at $8.98 on April 2, 2026. Melissa Pagen, President & COO of BRZ, sold 89,004 shares at $9.14 on March 23, 2026.
Analysts Set New Price Targets
On May 18, 2026, HC Wainwright & Co. maintained its buy rating on United States Antimony with a price target of $11.75. The consensus among analysts is a strong buy, with a mean target price of $13.06 based on four analyst opinions.
About United States Antimony Corporation
United States Antimony Corporation produces and sells antimony, zeolite, and precious metals in the United States and Canada. The company operates in two main segments: Antimony and Zeolite. Its antimony products are used in flame retardants, batteries, and ammunition, while its zeolite is applied in a variety of industrial and environmental uses. The company, headquartered in Dallas, Texas, was founded in 1968 and is led by CEO Mr. Gary C. Evans.
Bottom Line
Jon Marinelli's recent purchase of United States Antimony shares highlights ongoing insider interest in the company. With a diverse product line and a strong buy analyst consensus, investors are closely watching this basic materials firm. As always, remember that insider trades are reported after the fact and may not reflect current positions.
Get United States Antimony Corporation alerts
New 13F filings, insider trades, and analyst moves on $UAMY, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.